These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25740290)

  • 1. Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years.
    Botha S; Fourie CM; Schutte R; Eugen-Olsen J; Schutte AE
    Hypertens Res; 2015 Jun; 38(6):439-44. PubMed ID: 25740290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population.
    Botha S; Fourie CMT; Schutte R; Eugen-Olsen J; Pretorius R; Schutte AE
    Int J Cardiol; 2015 Apr; 184():631-636. PubMed ID: 25771228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase plasminogen activator receptor (suPAR) is associated with metabolic changes in HIV-1-infected Africans: a prospective study.
    Fourie CM; Van Rooyen JM; Kruger A; Olsen MH; Eugen-Olsen J; Schutte R; Schutte AE
    Inflammation; 2012 Feb; 35(1):221-9. PubMed ID: 21384094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of suPAR with lifestyle and cardiometabolic risk factors.
    Botha S; Fourie CM; Schutte R; Kruger A; Schutte AE
    Eur J Clin Invest; 2014 Jul; 44(7):619-26. PubMed ID: 24810168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study.
    Schutte AE; Myburgh A; Olsen MH; Eugen-Olsen J; Schutte R
    Thromb Res; 2012 Aug; 130(2):273-7. PubMed ID: 22113150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix biomarker, fibulin-1 and its association with soluble uPAR in a bi-ethnic South African population: the SAfrEIC study.
    du Plooy CS; Kruger R; Huisman HW; Rasmussen LM; Eugen-Olsen J; Schutte AE
    Heart Lung Circ; 2015 Mar; 24(3):298-305. PubMed ID: 25456503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
    Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
    J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease.
    Park MY; Herrmann SM; Saad A; Eirin A; Tang H; Lerman A; Textor SC; Lerman LO
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):443-51. PubMed ID: 25542906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease.
    Jhee JH; Nam BY; Lee CJ; Park JT; Han SH; Kang SW; Park S; Yoo TH
    J Am Heart Assoc; 2021 Jan; 10(1):e017225. PubMed ID: 33325248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
    Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
    Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.
    Kokkinos A; Liaskos C; Alexiadou K; Papassotiriou I; Margeli A; Argyrakopoulou G; Perrea D; Alexandrou A; Katsilambros N; Diamantis T; Tentolouris N
    J Endocrinol Invest; 2021 Mar; 44(3):599-608. PubMed ID: 32681464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study.
    Schutte AE; Schutte R; Huisman HW; van Rooyen JM; Fourie CM; Malan NT; Malan L; Mels CM; Smith W; Moss SJ; Towers GW; Kruger HS; Wentzel-Viljoen E; Vorster HH; Kruger A
    Int J Epidemiol; 2012 Aug; 41(4):1114-23. PubMed ID: 22825590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
    Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
    J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation.
    Koh AS; Velmurugan B; Gao F; Tan RS; Wong JI; Teo LLY; Keng BMH; Chua SJM; Yuan JM; Koh WP; Cheung C
    BMC Geriatr; 2017 Nov; 17(1):275. PubMed ID: 29179674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
    Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
    J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals.
    Chew-Harris J; Appleby S; Richards AM; Troughton RW; Pemberton CJ
    Clin Biochem; 2019 Jul; 69():36-44. PubMed ID: 31129182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Urokinase Receptor and Chronic Kidney Disease.
    Hayek SS; Sever S; Ko YA; Trachtman H; Awad M; Wadhwani S; Altintas MM; Wei C; Hotton AL; French AL; Sperling LS; Lerakis S; Quyyumi AA; Reiser J
    N Engl J Med; 2015 Nov; 373(20):1916-25. PubMed ID: 26539835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.